SepScan Revenue
Biotechnology Research • 
London, England, United Kingdom • 1-10 Employees
$
SepScan revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | No funding |
Key Contact at SepScan
Jacob Breuer-Weil
Co-Founder
Company overview
| Headquarters | London, England, United Kingdom |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
About SepScan
SepScan is an innovative biotechnology startup focused on revolutionising Sepsis prognosis using fusion proteins! Our diagnostic kit aims to empower clinicians to accurately triage UTI patients by sepsis risk, enabling faster, life-saving interventions.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Manager
Employees by Department
SepScan has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
SepScan has never raised funding before.
Canada
Iran, Islamic Republic of
United States
France
AustraliaFrequently asked questions
SepScan is located in London, England, GB.
SepScan generates an estimated annual revenue of $513,330. This revenue figure reflects the company's market position and business performance in its industry.
SepScan has an estimated valuation of $1,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
SepScan has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
